The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Paediatric Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
The global Paediatric Vaccine market size is expected to reach US$ 31130 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of Paediatric Vaccine in various end use industries. The expanding demands from the Age (0-3), Age (3-12) and Age Above 12,, are propelling Paediatric Vaccine market. Pneumococcal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Varicella segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Paediatric Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Paediatric Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Paediatric Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Paediatric Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Paediatric Vaccine covered in this report include GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Pfizer, F. Hoffmann-La Roche and Novo Nordisk, etc.
The global Paediatric Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Global Paediatric Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Paediatric Vaccine market, Segment by Type:
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Global Paediatric Vaccine market, by Application
Age (0-3)
Age (3-12)
Age Above 12
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Paediatric Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Paediatric Vaccine market size is expected to reach US$ 31130 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of Paediatric Vaccine in various end use industries. The expanding demands from the Age (0-3), Age (3-12) and Age Above 12,, are propelling Paediatric Vaccine market. Pneumococcal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Varicella segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Paediatric Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Paediatric Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Paediatric Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Paediatric Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Paediatric Vaccine covered in this report include GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Pfizer, F. Hoffmann-La Roche and Novo Nordisk, etc.
The global Paediatric Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Global Paediatric Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Paediatric Vaccine market, Segment by Type:
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines
Global Paediatric Vaccine market, by Application
Age (0-3)
Age (3-12)
Age Above 12
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Paediatric Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Paediatric Vaccine
1.1 Paediatric Vaccine Market Overview
1.1.1 Paediatric Vaccine Product Scope
1.1.2 Paediatric Vaccine Market Status and Outlook
1.2 Global Paediatric Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Paediatric Vaccine Market Size by Region (2018-2029)
1.4 Global Paediatric Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Paediatric Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Paediatric Vaccine Market Size (2018-2029)
1.6.1 North America Paediatric Vaccine Market Size (2018-2029)
1.6.2 Europe Paediatric Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Paediatric Vaccine Market Size (2018-2029)
1.6.4 Latin America Paediatric Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Paediatric Vaccine Market Size (2018-2029)
2 Paediatric Vaccine Market by Type
2.1 Introduction
2.1.1 Pneumococcal
2.1.2 Varicella
2.1.3 Combinations
2.1.4 Poliovirus
2.1.5 Hepatitis
2.1.6 MMR
2.1.7 Pediatric Hormones
2.1.8 HIB
2.1.9 Allergy and Respiratory vaccines
2.1.10 Other Pediatric vaccines
2.2 Global Paediatric Vaccine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Paediatric Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Paediatric Vaccine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Paediatric Vaccine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Paediatric Vaccine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Paediatric Vaccine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Paediatric Vaccine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Paediatric Vaccine Revenue Breakdown by Type (2018-2029)
3 Paediatric Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Age (0-3)
3.1.2 Age (3-12)
3.1.3 Age Above 12
3.2 Global Paediatric Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Paediatric Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Paediatric Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Paediatric Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Paediatric Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Paediatric Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Paediatric Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Paediatric Vaccine Revenue Breakdown by Application (2018-2029)
4 Paediatric Vaccine Competition Analysis by Players
4.1 Global Paediatric Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2022)
4.3 Date of Key Players Enter into Paediatric Vaccine Market
4.4 Global Top Players Paediatric Vaccine Headquarters and Area Served
4.5 Key Players Paediatric Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Paediatric Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithCline
5.1.1 GlaxoSmithCline Profile
5.1.2 GlaxoSmithCline Main Business
5.1.3 GlaxoSmithCline Paediatric Vaccine Products, Services and Solutions
5.1.4 GlaxoSmithCline Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithCline Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Paediatric Vaccine Products, Services and Solutions
5.2.4 Merck Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Paediatric Vaccine Products, Services and Solutions
5.3.4 Sanofi Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Paediatric Vaccine Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Paediatric Vaccine Products, Services and Solutions
5.5.4 Abbott Laboratories Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Paediatric Vaccine Products, Services and Solutions
5.6.4 Eli Lilly Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Paediatric Vaccine Products, Services and Solutions
5.7.4 Pfizer Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 F. Hoffmann-La Roche
5.8.1 F. Hoffmann-La Roche Profile
5.8.2 F. Hoffmann-La Roche Main Business
5.8.3 F. Hoffmann-La Roche Paediatric Vaccine Products, Services and Solutions
5.8.4 F. Hoffmann-La Roche Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.8.5 F. Hoffmann-La Roche Recent Developments
5.9 Novo Nordisk
5.9.1 Novo Nordisk Profile
5.9.2 Novo Nordisk Main Business
5.9.3 Novo Nordisk Paediatric Vaccine Products, Services and Solutions
5.9.4 Novo Nordisk Paediatric Vaccine Revenue (US$ Million) & (2018-2023)
5.9.5 Novo Nordisk Recent Developments
6 North America
6.1 North America Paediatric Vaccine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Paediatric Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Paediatric Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Paediatric Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Paediatric Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Paediatric Vaccine Market Dynamics
11.1 Paediatric Vaccine Industry Trends
11.2 Paediatric Vaccine Market Drivers
11.3 Paediatric Vaccine Market Challenges
11.4 Paediatric Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
